Recent developments in HIV and the kidney
- 1 February 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 22 (1) , 43-48
Abstract
Antiretroviral therapy has been immensely successful in reducing the incidence of opportunistic infections and death after HIV infection. This has resulted in heightened interest in noninfectious comorbidities including kidney disease. This review focuses on recent progress in our understanding of the clinical epidemiology of HIV-associated kidney disease. Acute renal failure in the highly active antiretroviral therapy era is associated with delayed HIV diagnosis. The incidence of acute renal failure rapidly declines in patients who receive HIV care, which includes the provision of highly active antiretroviral therapy to patients with advanced HIV infection. The prevalence of chronic kidney disease among HIV-infected patients is approximately 17%, and chronic kidney disease is associated with older age, advanced HIV infection, metabolic and vascular disease, and use of indinavir and tenofovir. Black patients are at increased risk of progression to end-stage renal disease, particularly if not receiving highly active antiretroviral therapy. Although survival of patients requiring dialysis remains poor, renal transplantation is an increasingly promising treatment modality for HIV-associated end-stage renal disease. The various forms of HIV-associated kidney dysfunction are now much better defined. The burden of chronic kidney disease is likely to escalate as a result of increasing life expectancy and ageing of HIV-infected patients.Keywords
This publication has 62 references indexed in Scilit:
- Risk Factors for Proteinuria in HIV-Infected and -Uninfected Hispanic Drug UsersAmerican Journal of Kidney Diseases, 2008
- Association of Hepatitis C Virus Infection With Prevalence and Development of Kidney DiseaseAmerican Journal of Kidney Diseases, 2008
- Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney diseaseAIDS, 2008
- Survival during Renal Replacement Therapy among African Americans Infected with HIV Type 1 in Urban Baltimore, MarylandClinical Infectious Diseases, 2007
- Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus InfectionThe FRAM StudyArchives of internal medicine (1960), 2007
- Proteinuria and Endothelial Dysfunction in Stable HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Microalbuminuria in HIV infectionAIDS, 2007
- In Vitro Cytotoxicity and Mitochondrial Toxicity of Tenofovir Alone and in Combination with Other Antiretrovirals in Human Renal Proximal Tubule CellsAntimicrobial Agents and Chemotherapy, 2006
- Mechanism of Active Renal Tubular Efflux of TenofovirAntimicrobial Agents and Chemotherapy, 2006
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004